A phase II evaluation of nintedanib (BIBF-1120) in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group Study

Don S. Dizon, Michael W. Sill, Jeanne M. Schilder, Kathryn F. McGonigle, Zia Ur Rahman, David S. Miller, David G. Mutch, Kimberly K. Leslie

Gynecologic Oncology · 2014 · 89 citations · 33 references

DOIFull text

Open access

Concepts

References

33